...
首页> 外文期刊>Biochimica et biophysica acta. Reviews on cancer >CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods
【24h】

CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods

机译:CRISPR / CAS9系统作为创新的基因工程工具:序列特异性和递送方法的增强

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

While human gene therapy has gained significant attention for its therapeutic promise, CRISPR/Cas9 technology has made a breakthrough as an efficient genome editing tool by emulating prokaryotic immune defense mechanisms. Although many studies have found that CRISPR/Cas9 technology is more efficient, specific and manipulable than previous generations of gene editing tools, it can be further improved by elevating its overall efficiency in a higher frequency of genome modifications and reducing its off-target effects. Here, we review the development of CRISPR/Cas9 technology, focusing on enhancement of its sequence specificity, reduction of off-target effects and delivery systems. Moreover, we describe recent successful applications of CRISPR/Cas9 technology in laboratory and clinical studies. (C) 2015 Elsevier B.V. All rights reserved.
机译:虽然人类基因治疗对其治疗承诺进行了重大关注,但通过模拟原核免疫防御机制,CRISPR / CAS9技术通过模拟原始的免疫防御机制来实现了一种有效的基因组编辑工具的突破。 尽管许多研究发现CRISPR / CAS9技术比以前几代基因编辑工具更有效,具体和可操纵,但是通过在更高频率的基因组修饰中提高其整体效率并降低其脱靶效果,可以进一步提高。 在这里,我们审查了CRISPR / CAS9技术的开发,重点是增强其序列特异性,减少了脱靶效果和输送系统。 此外,我们在实验室和临床研究中描述了CRISPR / CAS9技术的最近成功应用。 (c)2015 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号